Cargando…
Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
Digital ulcers are a well-known problem in patients with systemic sclerosis. Lower extremity ulcers are less prevalent but are also a challenging and underestimated complication of the disease causing important pain and morbidity. Bosentan, an oral dual endothelin receptor antagonist, has been shown...
Autores principales: | Naert, Alix, De Haes, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638571/ https://www.ncbi.nlm.nih.gov/pubmed/23653656 http://dx.doi.org/10.1155/2013/690591 |
Ejemplares similares
-
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
por: Di Poi, Emma, et al.
Publicado: (2023) -
Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
por: Álvarez Reyes, Fátima, et al.
Publicado: (2011) -
Successful Use of Tofacitinib in Scleroderma Arthropathy
por: MV, Prakashini, et al.
Publicado: (2023) -
Digital ulcers secondary to Sneddon’s syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis
por: Barnini, Tommaso, et al.
Publicado: (2012) -
Bilateral lower extremity ulcerations, less is more
por: Potter, Kathryn Mooneyham, et al.
Publicado: (2019)